Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107889504B reveals PRPP-free NMN synthesis. Enhanced enzyme stability and scalability for reliable high-purity nutritional ingredient supply chains.
Patent CN102978272B reveals enzymatic synthesis for water soluble phytosterols. Enhances bioavailability and supply chain reliability for nutritional ingredients manufacturing.
Patent CN113337494B reveals high-purity enzymatic synthesis reducing waste and cost for reliable pharmaceutical intermediates supply chains globally.
Patent CN104774891A details enzymatic synthesis of Cbz-APM. Offers high purity, cost reduction in sweetener manufacturing, and reliable supply chain solutions.
Patent CN116987748A reveals one-step enzymatic route for pseudouridylic acid. Offers high yield and cost reduction for pharmaceutical intermediates manufacturing supply chains.
Patent CN113621663A reveals a novel enzymatic route for Ezetimibe, offering high purity and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN105603028B reveals dual-enzyme process for glutathione and adenylate. Reduces ATP cost and simplifies purification for reliable supply chain partners.
Patent CN101906445A reveals a mild enzymatic route for coumarin derivatives, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113817693A reveals a breakthrough PpYSDR mutant for testosterone synthesis, offering superior yield and greener manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN102586356B reveals an eco-friendly enzymatic route for quinoline heterocycles, offering high yields and reduced waste for pharmaceutical manufacturing.
Patent CN105461606A reveals enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de purity and scalable green manufacturing for Hepatitis C drug supply chains.
Patent CN102899367B details a hybrid bio-chemical synthesis for high-purity Tenofovir. This method offers significant cost reduction and scalable manufacturing for API intermediates.
Patent CN104152525A reveals dynamic kinetic resolution for R-1-phenylethylamine. Achieve high yield and purity with cost-effective Raney nickel catalysts for supply chain stability.
Novel nitrile hydratase mutant enables green cinnamamide production. Significant activity boost ensures cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102226213B details enzymatic betulinic acid production. Offers safe, scalable pharmaceutical intermediate manufacturing with reduced environmental impact.
Enzymatic synthesis patent CN100396782C offers high purity stable isotope labeled amino acids with streamlined extraction and superior 15N utilization for research.
Patent CN113736842B reveals high-purity TUDCA production via multi-cell catalysis. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN103224972B reveals high-yield enzymatic synthesis. Offers supply chain stability and cost efficiency for pharmaceutical manufacturers seeking reliable amino acid intermediates.
Patent CN112063670A reveals a stable adenylate cyclase method for cAMP production, offering reliable pharmaceutical intermediates supply with significant cost and environmental advantages.
Patent CN116121310A reveals a high-efficiency enzymatic route for dexketoprofen, offering superior purity and scalable production for reliable pharmaceutical intermediates suppliers.